CHU Lapeyronie   Report issue

Academic/Hospital Phase 4
Founded: France (1918)

Organization Overview

First Clinical Trial
2011
NCT02813642
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

CHU Lapeyronie, Department of Biochemistry and Hormonology, Montpellier, FRANCE